Clinical Trial Update: Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) [Phase 1]

View source ↗

Summary

Phase 1 SABRE trial evaluating selective antigen-specific T cells and CAR T cells in relapsed/refractory embryonal tumors, including rhabdomyosarcoma, Ewing sar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• CAR T cells (SABRE) (Chimeric antigen receptor T cells)
• Selective antigen-specific T cells (Selective antigen-specific T cells)

Snippet

Sponsor: Children's National Research Institute | Conditions: Rhabdomyosarcoma, Ewing Sarcoma | Phase 1 | Status: RECRUITING